This is an official version.

Copyright ©2022: Queen's Printer,
St. John's, Newfoundland and Labrador, Canada

Important Information
(Includes details about the availability of printed and electronic versions of the Statutes.)

Newfoundland and Labrador
Regulation 2022


NEWFOUNDLAND AND LABRADOR REGULATION 31/22

NEWFOUNDLAND AND LABRADOR
REGULATION 31/22

Authorization to Prescribe Regulations (Amendment)
under the
Pharmacy Act, 2012

(Filed May 12, 2022)

Under the authority of section 59 of the Pharmacy Act, 2012, the Newfoundland and Labrador Pharmacy Board, with the approval of the Minister of Health and Community Services makes the following regulations.

Dated at St. John’s, April 28, 2022.

Taggarty Norris
Chairperson, Newfoundland and
Labrador Pharmacy Board

Dr. John Haggie
Minister of Health and Community Services

REGULATIONS

Analysis


        1.   S.3 Amdt.
Prescribing by pharmacists

        2.   S.4 Amdt.
Authorization to prescribe generally

        3.   S.11 R&S
Schedule 1 drugs

        4.   S.12 Amdt.
Duty to obtain informed consent


NLR 73/15
as amended

        1. (1) Paragraph 3(a) of the Authorization to Prescribe Regulations is amended by deleting the words "his or her" and substituting the words "the pharmacist's".

             (2)  Paragraph 3(c) of the regulations is amended by deleting the word "and" at the end of subparagraph (vi), deleting the period at the end of subparagraph (vii) and substituting a comma and the word "and" and adding immediately after that subparagraph the following:

                  (viii)  prescribing for the prevention or treatment of COVID-19.

 

        2. Paragraph 4(1)(b) of the regulations is repealed and the following substituted:

             (b)  provides proof satisfactory to the board of the completion of the educational and training requirements prescribed by the board; and

 

        3. Section 11 of the Act is repealed and the following substituted:

Schedule I drugs

      11. A pharmacist authorized under section 4 may, in addition to prescribing a drug referred to in section 10, prescribe a Schedule I drug where

             (a)  that drug is indicated for the treatment of a minor ailment;

             (b)  that drug is indicated for the prevention of a preventable disease;

             (c)  that drug is indicated for the prevention or treatment of COVID-19; or

             (d)  that prescribing falls into a category referred to in subparagraphs 3(c)(i), (ii), (iii) or (iv).

 

        4. (1) Subsection 12(1) of the regulations is repealed and the following substituted:

Duty to obtain informed consent

      12. (1) A pharmacist authorized under section 4 who intends to prescribe under these regulations shall ensure that informed consent is obtained before so prescribing.

             (2)  Subsection 12(2) of regulations is amended by deleting the words "his or her" and substituting the words "the person's".

             (3)  Subsection 12(3) of the regulations is amended by deleting the words "his or her" and substituting the words "the person's".